Combination therapy of Ad-mda7 and trastuzumab increases cell death in Her-2/neu–overexpressing breast cancer cells
- 31 August 2004
- Vol. 136 (2) , 437-442
- https://doi.org/10.1016/j.surg.2004.05.022
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- MDA-7 negatively regulates the β-catenin and PI3K signaling pathways in breast and lung tumor cellsMolecular Therapy, 2003
- Adenoviral melanoma differentiation-associated gene 7 induces apoptosis in lung cancer cells through mitochondrial permeability transition-independent cytochrome c releaseThe Journal of Thoracic and Cardiovascular Surgery, 2003
- HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cellsOncogene, 2003
- β-Catenin Signaling: Therapeutic Strategies in OncologyCancer Biology & Therapy, 2002
- The cancer growth suppressing gene mda-7 induces apoptosis selectively in human melanoma cellsOncogene, 2002
- A combinatorial approach for selectively inducing programmed cell death in human pancreatic cancer cellsProceedings of the National Academy of Sciences, 2001
- Tumor-suppressive effects by adenovirus-mediated mda-7 gene transfer in non-small cell lung cancer cell in vitroGene Therapy, 2000
- β-catenin: a key mediator of Wnt signalingCurrent Opinion in Genetics & Development, 1998
- PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyondTrends in Biochemical Sciences, 1997
- The melanoma differentiation associated gene mda-7 suppresses cancer cell growth.Proceedings of the National Academy of Sciences, 1996